Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
65
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0292
CTAP
NA
D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
NA
Cyclic
NA
NA
NA
NA
NA
NA
NA
Adult Sprague-Dawley rats
NA
in situ brain perfusion technique coupled to high performance liquid chromatographic analysis.
NA
T1/2 > 500 min
NA
NA
NA
NA
NA
half life, serum
T1/2 > 500 min
NA
8996221
b3pdb_0421
Vapreotide
fCYwKVCW-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Trp-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)Cc7c6ccccc6nc7
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Permeability surface area cofficient
20.3 µL/(g x min)
Direct iodination
1975697
b3pdb_0440
Vasoactive intestina
HSDAVFTDNYTRLRKQMAVKKYLNSILN
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn
NA
NA
NA
28
Linear
NA
human,bovine,mouse,rat,porcine
CCC(C)C(NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(NC(=O)C(C)NC(=O)C(CCSC)NC(=O)C(CCC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(N)=N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(N)=O)NC(=O)C(CC(O)=O)NC(=O)C(NC(=O)C(CC1=CC=CC=C1)NC(=O)C(NC(=O)C(C)NC(=O)C(CC(O)=O)NC(=O)C(CO)NC(=O)C(N)CC1=CN=CN1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(N)=O)C(N)=O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.00216 mL/(g x min)
Direct iodination
12732342
b3pdb_0459
Exendin-4
HGEGTFTSDLSKQMEEEAVRLFIEWLKNGGPSSGAPPPS
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser
NA
NA
NA
39
Linear
NA
human,bovine,mouse,rat,porcine
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O) NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC (CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(= O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C) C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C (CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C (CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC (=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CN=CN9)N
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Unidirectional flux rate constant
0.01895 mL/(g x min)
Direct iodination
12629557
b3pdb_0470
Phe13,Tyr19-Melanin
DFDMLRCMLGRVFRPCWQY
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr
NA
NA
Cys7-Cys16
19
Linear
NA
mouse,rat
[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.00137 ml/g
Direct iodination
10617143
b3pdb_0471
Phe13,Tyr19-Melanin
DFDMLRCMLGRVFRPCWQY
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr
NA
NA
Cys7-Cys16
19
Linear
NA
mouse,rat
[H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC1=O)C(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.000594 mL/(g x min)
Direct iodination
10617143
b3pdb_0484
Urocortin-I
DDPPLSIDLTFHLLRTLLELARTQSQRERAEQNRIIFDSV-NH2
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2
NA
40
Linear
NA
frog
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.000676 mL/(g x min)
Direct iodination
11280710
b3pdb_0491
Insulin
A-chain:GIVEQCCTSICSLYQLENYCN B-chain: FVNQHLCGSHLVEALYLVCGERGFFYTPKT
A-chain: Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Asn B-chain:Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr
NA
NA
Cys6A-Cys11A, Cys7A-Cys7B, Cys19B-Cys20A
51
Linear
NA
human,rat
[H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N[H])CC2=CC=CC=C2)C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)NC1=O)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.00086 mL/(g x min)
Direct iodination
15228601
b3pdb_0552
Melanocyte-stimulati
PLG-NH2
Pro-Leu-Gly-NH2
NA
NA
NA
3
Linear
NA
human,bovine
CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Unidirectional flux rate constant
0.00234 mL/(g x min)
Direct iodination
8786534
b3pdb_0553
Melanocyte-stimulati
PLG-NH2
Pro-Leu-Gly-NH2
NA
NA
NA
3
Linear
NA
human,bovine
CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.0189 ml/g
Direct iodination
8786534
b3pdb_0554
Melanocyte-stimulati
PLG-NH2
Pro-Leu-Gly-NH2
NA
NA
NA
3
Linear
NA
human,bovine
CC(C)CC(C(=O)NCC(=O)N)NC(=O)C1CCCN1
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
permiability constant
0.00000039 cm/s
Direct iodination
8786534
b3pdb_0560
Tyr-Melanocyte-stimu
YPLG
Tyr-Pro-Leu-Gly
NA
NA
NA
4
Linear
NA
bovine
O=C(NC(C(=O)NCC(=O)O)CC(C)C)C2N(C(=O)C(N)Cc1ccc(O)cc1)CCC2
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Unidirectional flux rate constant
0.00146 mL/(g x min)
H3/C14
8769896
b3pdb_0561
Tyr-Melanocyte-stimu
YPLG
Tyr-Pro-Leu-Gly
NA
NA
NA
4
Linear
NA
bovine
O=C(NC(C(=O)NCC(=O)O)CC(C)C)C2N(C(=O)C(N)Cc1ccc(O)cc1)CCC2
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Initial distribution vaolume
0.036 ml/g
H3/C14
8769896
b3pdb_0569
Tyr-Melanocyte-stimu
YPLG
Tyr-Pro-Leu-Gly
NA
NA
NA
4
Linear
NA
bovine
O=C(NC(C(=O)NCC(=O)O)CC(C)C)C2N(C(=O)C(N)Cc1ccc(O)cc1)CCC2
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.00226 mL/(g x min)
H3/C14
8769896
b3pdb_0570
Tyr-Melanocyte-stimu
YPLG
Tyr-Pro-Leu-Gly
NA
4
Linear
NA
bovine
O=C(NC(C(=O)NCC(=O)O)CC(C)C)C2N(C(=O)C(N)Cc1ccc(O)cc1)CCC2
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
saturable
NA
NA
NA
in vitro influx rate
3.54%
Direct iodination
11337097
b3pdb_0575
Biphalin
YaGF-NH-NH-FGaY
Tyr-(D)Ala-Gly-Phe-NH-NH-Phe-Gly-(D)Ala-Tyr
NA
NA
NA
8
Linear
NA
cat
O=C(N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)NNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccccc3)C)[C@@H](N)Cc4ccc(O)cc4
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.001 mL/(g x min)
Direct iodination
11714884
b3pdb_0576
Biphalin
YaGF-NH-NH-FGaY
Tyr-(D)Ala-Gly-Phe-NH-NH-Phe-Gly-(D)Ala-Tyr
NA
NA
NA
8
Linear
NA
cat
O=C(N[C@@H](C(=O)NCC(=O)N[C@H](C(=O)NNC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccccc3)C)[C@@H](N)Cc4ccc(O)cc4
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.0097 ml/g
Direct iodination
11714884
b3pdb_0584
D-Penicillamine-D-Pe
Y-Pen-GF-Pen
Tyr-(D)Pen-Gly-Phe-(D)Pen
NA
NA
(D)Pen2-(D)Pen5
5
Linear
NA
human
O=C(O)[C@@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(SSC2(C)C)(C)C)Cc3ccccc3
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.0022 mL/(g x min)
Direct iodination
11714884
b3pdb_0585
D-Penicillamine-D-Pe
Y-Pen-GF-Pen
Tyr-(D)Pen-Gly-Phe-(D)Pen
NA
NA
(D)Pen2-(D)Pen5
5
Linear
NA
human
O=C(O)[C@@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(SSC2(C)C)(C)C)Cc3ccccc3
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.0143 ml/g
Direct iodination
11714884
b3pdb_0594
SAM 995
YtGFLS-NH2
Tyr-(D)Thr-Gly-Phe-Leu-Ser-NH2
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C(O)C)Cc2ccccc2)CC(C)C)CO
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Volume of donor compartment
0.1678 ml/g
NA
1357139
b3pdb_0609
Nesfatin-1
VPIDVDKTKVHNVEPVESARIEPPDTGLYYDEYLKQVIEVLETDPHFREKLQKADIEEIRSGRLSQELDLVSHKVRTRLDEL
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu
NA
NA
NA
82
Linear
NA
NA
[H]N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](CO)C(=O)N[C@@H](C)C(=O)N[C@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@H](CC(O)=O)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](CCC(O)
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.0003049 mL/(g x min)
Direct iodination
18006117
b3pdb_0640
Urocortin II
VILSLDVPIGLLRILLEQARYKAARNQAATNAQILAHV
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val
NA
NA
NA
38
Linear
NA
rat
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.02021 mL/(g x min)
Direct iodination
12065889
b3pdb_0651
Luteinizing hormone-
Pyr-HWSYGLRPG
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
NA
NA
NA
10
Linear
NA
mouse
O=C(NCC(=O)O)[C@H]6N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H]1NC(=O)CC1)Cc2ncnc2)Cc4c3ccccc3nc4)CO)Cc5ccc(O)cc5)CC(C)C)CCCNC(=[N@H])N)CCC6
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Unidirectional flux rate constant
0.01251 mL/(g x min)
Direct iodination
1887877
b3pdb_0652
Luteinizing hormone-
Pyr-HWSYGLRPG
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
NA
NA
NA
10
Linear
NA
mouse
O=C(NCC(=O)O)[C@H]6N(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@H]1NC(=O)CC1)Cc2ncnc2)Cc4c3ccccc3nc4)CO)Cc5ccc(O)cc5)CC(C)C)CCCNC(=[N@H])N)CCC6
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Permeability surface area cofficient
0.02 µL/(g x min)
Direct iodination
1887877
b3pdb_0658
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.000573 mL/(g x min)
Direct iodination
12130749
b3pdb_0659
Des-octanoyl ghrelin
GSSFLSPEHQKAQQRKESKKPPAKLQPR
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
NA
NA
NA
28
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Initial distribution vaolume
0.011 ml/g
Direct iodination
12130749
b3pdb_0667
Peptide YY (3-36)
IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr
NA
NA
NA
32
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.00234 mL/(g x min)
Direct iodination
12750431
b3pdb_0677
JMV 2012
KKPYILKKPYIL
Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu
NA
NA
NA
12
Linear
NA
human,mouse,rat
O=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
saturable
NA
NA
NA
Unidirectional flux rate constant
0.00339 mL/(g x min)
Direct iodination
8786534
b3pdb_0678
JMV 2012
KKPYILKKPYIL
Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu
NA
NA
NA
12
Linear
NA
human,mouse,rat
O=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Initial distribution vaolume
0.0267 ml/g
Direct iodination
8786534
b3pdb_0679
JMV 2012
KKPYILKKPYIL
Lys-Lys-Pro-Tyr-Ile-Leu-Lys-Lys-Pro-Tyr-Ile-Leu
NA
NA
NA
12
Linear
NA
human,mouse,rat
O=C(NC(C(=O)N1CCCC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3C(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(C)C)C(C)CC)Cc2ccc(O)cc2)CCC3)CCCCN)CCCCN)CC(C)C)C(C)CC)Cc4ccc(O)cc4)CCCCN)C(N)CCCCN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
permiability constant
0.000000565 cm/s
Direct iodination
8786534
b3pdb_0684
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Initial distribution vaolume
0.0191 ml/g
H3/C14
8996221
b3pdb_0685
Connective tissue-ac
fCYwRT-Pen-T-NH2
(D)Phe-Cys-Tyr-(D)Trp-Arg-Thr-Pen-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCNC(=[N@H])N)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional flux rate constant
0.00161 mL/(g x min)
H3/C14
8996221
b3pdb_0695
LSZ 1025
YcGFcSG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
rat,porcine
O=C(N)CNC(=O)[C@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00079 ml/(g x min)
Direct iodination
11033091
b3pdb_0697
LSZ 1025
YcGFc-(β-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@H](O)C(O)[C@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00157 ml/(g x min)
Direct iodination
11033091
b3pdb_0699
LSZ 62
YcGFc-(α-D-Glc)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(α-D-Glucose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@H]4OC(CO)[C@H](O)C(O)[C@@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00133 ml/(g x min)
Direct iodination
11033091
b3pdb_0701
SAM 1025
YcGFc-(β-D-Glc)sG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Glucose) (D)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@@H](NC(=O)[C@@H]2NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4OC(CO)[C@@H](O)C(O)[C@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00057 ml/(g x min)
Direct iodination
11033091
b3pdb_0703
SAM 1040
YcGFc-(β-D-Xyl)SG-NH2
Tyr-(D)Cys-Gly-Phe-(D)Cys-(β-D-Xylose)Ser-Gly-NH2
(D)Cys2-(D)Cys5
7
Linear
NA
Chemically synthesized
O=C(N)CNC(=O)[C@H](NC(=O)[C@@H]2NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)CSSC2)Cc3ccccc3)CO[C@@H]4O[C@H](CO)C(O)[C@@H]4O
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant,initial
0.00133 ml/(g x min)
Direct iodination
11033091
b3pdb_0715
Glycylsarcosine
G-Sar
Gly-Sar
NA
2
Linear
NA
human
O=C(N(C)CC(=O)O)CN
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional flux rate constant
0.0076 mL/(g x min)
NA
30962462
b3pdb_0720
[(D)Ala2,(D)Leu5] En
YaGFl
Tyr-(D)Ala-Gly-Phe-(D)Leu
NA
NA
NA
5
Linear
NA
human,porcine
O=C(O)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)CC(C)C
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Apparent permiability cofficient
0.00000005 cm/s
NA
18855917, 12388672
b3pdb_0744
Dalargin
YaGFLR
Tyr-(D)Ala-Gly-Phe-Leu-Arg
NA
NA
NA
6
Linear
NA
Chemically synthesized
O=C(O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)CC(C)C)CCCNC(=[N@H])N
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.0167 ml/g
H3/C14
12682214
b3pdb_0870
Acyloxyalkoxy-based
cyclo(YaGFl) linker: -COOCH2O-
cyclo(Tyr-(D)-Ala-Gly-Phe-(D)Leu) linker: -COOCH2O-
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Apparent permiability cofficient
0.00000012 cm/s
NA
18855917, 12388672
b3pdb_0871
Coumarinic acid-base
cyclo(YaGFl) linker: -COC=C-phenoxy-(coumarinic acid)
cyclo(Tyr-(D)-Ala-Gly-Phe-(D)-Leu) linker: -COC=C-phenoxy-(coumarinic acid)
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Apparent permiability cofficient
0.00000004 cm/s
NA
18855917, 12388672
b3pdb_0872
Oxymethyl-modified c
cyclo(YaGFl) linker:-COC=C-phenoxy-CH2O- (oxymethyl coumarinic acid)
cyclo(Tyr-(D)-Ala-Gly-Phe-(D)-Leu) linker: -COC=C-phenoxy-CH2O- (oxymethyl coumarinic acid)
NA
NA
NA
5
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Apparent permiability cofficient
0.00000007 cm/s
NA
18855917, 12388672
b3pdb_0873
Dalargin-SS-SynB1
YaGFLR-NHC2H4S-SC2H4NH-RGGRLSYSRRRFSTSTGR-NH2
Tyr-(D)Ala-Gly-Phe-Leu-Arg-NHC2H4S-SC2H4NH-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg-NH2
NA
NA
Cys-Cys (linker)
20
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.309 ml/g
H3/C14
12682214
b3pdb_0874
Dalargin-SS-SynB3
YaGFLR-C2H4S-SC2H4-RRLSYSRRRF-NH2
Tyr-(D)Ala-Gly-Phe-Leu-Arg-NHC2H4S-SC2H4NH-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-NH2
NA
NA
Cys-Cys (linker)
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.24 ml/g
H3/C14
12682214
b3pdb_0905
Angiopep-7
TFFYGGSRGRRNNFRTEEY
Thr-Phe-Phe-Tyr-Gly-Gly-Ser-Arg-Gly-Arg-Arg-Asn-Asn-Phe-Arg-Thr-Glu-Glu-Tyr
NA
19
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
% injected dose
0.22 %/g
Direct iodination
29090274
b3pdb_0969
Doxorubicin-SynB1
Doxorubicin-linker-RGGRLSYSRRRFSTSTGR
Doxorubicin-linker-Arg-Gly-Gly-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-Ser-Thr-Ser-Thr-Gly-Arg
NA
NA
NA
18
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.0684 mL/(g x min)
H3/C14
12164379
b3pdb_0970
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.77764 ml/g
H3/C14
11123372
b3pdb_0971
Doxorubicin-(D)-Pene
Doxorubicin-linker-rqikiwfqnrrmkwkk
Doxorubicin-linker-(D)Arg-(D)Gln-(D)Ile-(D)Lys-(D)Ile-(D)Trp-(D)Phe-(D)Gln-(D)Asn-(D)Arg-(D)Arg-(D)Met-(D)Lys-(D)Trp-(D)Lys-(D)Lys
NA
NA
NA
16
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.072 mL/(g x min)
H3/C14
10727512
b3pdb_0972
Doxorubicin-SynB3
Doxorubicin-linker-RRLSYSRRRF
Doxorubicin-linker-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe
NA
NA
NA
10
Linear
NA
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.1386 mL/(g x min)
H3/C14
10727512
previous
1
2
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD
